Latest Executive Appointments News

Vanadium Resources Limited is advancing multiple offtake discussions for its Steelpoortdrift project, with competing proposals offering improved terms over existing agreements. Operational readiness steps are progressing, including key executive appointments and contractor finalisations.

Sonic Healthcare announces a major leadership transition with Dr Colin Goldschmidt retiring after 32 years as CEO, succeeded by Dr Jim Newcombe. The company also appoints Evangelos Kotsopoulos as Chief Operating Officer to support its global growth ambitions.

Gumtree Australia Markets has officially appointed Tommy Logtenberg as Managing Director, cementing his leadership role after serving as CEO since 2023. The move signals continuity and confidence in the company’s strategic direction.

JAYRIDE Group Limited has confirmed Randy Prado as CEO and Ram Navaratnam as Finance Director, cementing leadership as it advances its SaaS mobility platform with pilots in Southeast Asia.

Alligator Energy strengthens its executive team with key appointments as it shifts from exploration to uranium production, closing its Brisbane office and centralising operations in Adelaide.

DigiCo Infrastructure REIT has appointed Michael Juniper as a senior executive and director, aiming to leverage his extensive experience to accelerate growth and sustainability in its data centre portfolio.

Spenda Limited announces the resignation of CEO Adrian Floate due to health concerns, appointing COO Corrie Hassan as interim CEO and welcoming Francis DeSouza to the Board. The company aims to maintain momentum following a record revenue year.

King River Resources has appointed seasoned geologist and executive Graham Gadsby as Managing Director, aiming to leverage his proven track record in gold exploration and operational turnarounds to drive the company’s future growth.

Coventry Group Ltd has appointed Nik Alpert as Managing Director, marking a key leadership transition with no changes to his existing remuneration package.

Nanoveu Limited’s transformative half-year report highlights its EMASS acquisition, executive hires, and technology advances amid a $3 million loss and new US OTCQB listing.

DorsaVi Limited reported a 13.9% revenue decline and a 21.7% rise in net loss for FY25, while securing over $3 million in capital to fuel new technology ventures.

Algorae Pharmaceuticals reported a 62% reduction in net loss for FY2025, driven by R&D tax credits and cost efficiencies, while making significant strides in its AI drug discovery platform and therapeutic candidates.